Mersana Therapeutics
MRSN
MRSN
105 hedge funds and large institutions have $273M invested in Mersana Therapeutics in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 34 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less call options, than puts
Call options by funds: $962K | Put options by funds: $1M
18% less funds holding
Funds holding: 128 → 105 (-23)
55% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 40
Holders
105
Holding in Top 10
2
Calls
$962K
Puts
$1M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$13.9M | |
| 3 | +$10.8M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$5.26M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.29M |
Top Sellers
| 1 | -$6.63M | |
| 2 | -$4.29M | |
| 3 | -$2.85M | |
| 4 |
Walleye Capital
New York
|
-$2.57M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$2.54M |